Capital Fund Management (CFM)’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-10,200
Closed -$976K 1605
2020
Q4
$976K Buy
+10,200
New +$1.05M 0.01% 997
2019
Q1
Sell
-8,800
Closed -$334K 2087
2018
Q4
$334K Buy
+8,800
New +$311K ﹤0.01% 1561

Other funds holding TNDM

Capital Fund Management (CFM)'s TNDM Position: Q1 2026 in Review

Capital Fund Management (CFM) sold out of Tandem Diabetes Care (TNDM) in Q1 2026, closing a stake of 38,400 shares — an estimated $844K sold.

Capital Fund Management (CFM) first reported a position in TNDM in Q2 2019 and held it in 21 quarters. The position peaked at $13M in Q4 2022. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

  • Capital Fund Management (CFM) reported no remaining Tandem Diabetes Care position as of Q1 2026 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 38,400 Tandem Diabetes Care shares in Q1 2026, an estimated $844K.
  • Capital Fund Management (CFM) first reported a position in Tandem Diabetes Care in Q2 2019 and held it in 21 quarters.
  • Capital Fund Management (CFM)'s Tandem Diabetes Care position peaked at $13M in Q4 2022.
  • 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.